These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13583436)

  • 1. Observations on ambulatory tuberculous patients with pulmonary cavities and noninfectious sputum (the open-negative syndrome).
    BREUER J; ABELES H; CHAVES AD; ROBINS AB
    Am Rev Tuberc; 1958 Nov; 78(5):725-34. PubMed ID: 13583436
    [No Abstract]   [Full Text] [Related]  

  • 2. The fate of the patient with persistent cavitation and noninfectious sputum ("open-negative") after discharge from the hospital.
    CORPE RF; BLALOCK FA
    Am Rev Tuberc; 1958 May; 77(5):764-77. PubMed ID: 13533796
    [No Abstract]   [Full Text] [Related]  

  • 3. The syndrome of persistent cavitation and noninfectious sputum during chemotherapy and its relation to the open healing of cavities.
    AUERBACH O; SMALL MJ
    Am Rev Tuberc; 1957 Feb; 75(2):242-58. PubMed ID: 13403154
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory diagnostic procedures employed on sputum specimens from ambulatory tuberculous patients treated with isoniazid.
    WIDELOCK D; PEIZER LR; DANGLER G
    Am Rev Tuberc; 1954 Aug; 70(2):349-59. PubMed ID: 13180873
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients.
    HEATON AD; RUSSELL WF; DENST J; MIDDLEBROOK G
    J Clin Invest; 1959 Aug; 38(8):1376-83. PubMed ID: 13673094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observation in changes in the count of tubercle bacilli present in the sputum of tuberculous patients treated with anti-tuberculous agents].
    KAMEYAMA Y
    Kekkaku; 1956 Jul; 31(7):438-41. PubMed ID: 13346863
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of mycobacterial populations found in the sputum of tuberculous patients after prolonged isoniazid therapy.
    PEIZER LR; CHAVES AD; WIDELOCK D
    Am Rev Respir Dis; 1960 Oct; 82():568-73. PubMed ID: 13733935
    [No Abstract]   [Full Text] [Related]  

  • 8. [Variations in the bacilloscopic appearance of the sputum during the treatment of pulmonary tuberculosis with streptomycin].
    BALMES A; OULES R
    Sem Med; 1951 Sep 2-6; 27(48-49):603-7. PubMed ID: 14892833
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the results of the surgical and the nonsurgical treatment of tuberculous patients with the open-negative syndrome.
    BELL JW; DECKER AM; RALEIGH JW
    Am Rev Tuberc; 1957 Apr; 75(4):538-52. PubMed ID: 13411411
    [No Abstract]   [Full Text] [Related]  

  • 10. [The attitude of tubercle bacilli in sputum, especially on the smear positive and culture negative cases. I. Changes of the daily number of tubercle bacilli in sputum by chemotherapy].
    NISHIMURA H
    Kekkaku; 1956 Apr; 31(4):222-7. PubMed ID: 13320645
    [No Abstract]   [Full Text] [Related]  

  • 11. Open healing of tuberculous cavities; results in 40 patients treated conservatively.
    WILSON TM; DOYLE L; GARDINER MP
    Br Med J; 1958 Jul; 2(5088):87-90. PubMed ID: 13546656
    [No Abstract]   [Full Text] [Related]  

  • 12. Open healing of tuberculous cavities.
    KEERS RY; REID L; RIDDELL RW
    Tubercle; 1956 Dec; 37(6):404-16. PubMed ID: 13381026
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of underlying diabetes and presence of lung cavities on treatment outcomes in patients with pulmonary tuberculosis.
    Nakamura A; Hagiwara E; Hamai J; Taguri M; Terauchi Y
    Diabet Med; 2014 Jun; 31(6):707-13. PubMed ID: 24547904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the presence of Koch bacilli in the sputum of pulmonary tuberculosis patients treated in a sanatorium].
    LEVADITI JC
    Presse Med (1893); 1945 Aug; 53():443. PubMed ID: 21012069
    [No Abstract]   [Full Text] [Related]  

  • 15. [New viewpoints concerning therapy of tuberculous cavities].
    BREDNOW W
    Med Klin; 1956 Apr; 51(14):562-4. PubMed ID: 13333587
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis.
    Ahmad M; Ibrahim WH; Sarafandi SA; Shahzada KS; Ahmed S; Haq IU; Raza T; Hameed MA; Thomas M; Swehli HAI; Sattar HA
    Int J Infect Dis; 2019 May; 82():96-101. PubMed ID: 30904678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculous caverns of the lung with Koch negative sputum].
    DAMIANI F; LO CUZZO P
    Clin Nuova Rass Prog Med Int; 1950 Nov; 11(22):826-35. PubMed ID: 14839784
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and analysis of circulating tuberculous antigens in Mycobacterium tuberculosis.
    Shende N; Gupta S; Upadhye V; Kumar S; Harinath BC
    Indian J Tuberc; 2007 Jul; 54(3):125-9. PubMed ID: 17886700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations of bacteriological positivity in sputum in tuberculosis treated with p-aminosalicylic acid].
    LUCCHESI M; ROSSI S
    Ann Ist Carlo Forlanini; 1950; 12(5):543-6. PubMed ID: 24540302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isoniazide and transitory disappearances of Koch bacilli in sputum].
    DUPONT J
    Maroc Med; 1952 Oct; 31(329):811. PubMed ID: 13036312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.